Delivery Order SPE2DE21D0005-SPE2D625F230M

Award Date 10/29/24
Potential Completion Date 11/1/24
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The $1,239.95 fixed-price order is for the advanced wound care product APLIGRAF. This delivery order is part of a larger $49.5 million Indefinite Delivery Contract (IDC) the DLA has with Organogenesis for a variety of wound care dressings and medical supplies, which runs from June 2021 to June 2026. Organogenesis also...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....
This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The order is for $1,239.95 in APLIGRAF wound care products, with a completion date of March 29, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) that Organogenesis holds with the DLA for wound care dressings, discs, and other medical materials. Organogenesis has also...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This is a $1,239.95 fixed-price delivery order awarded to Organogenesis Inc., a leading regenerative medicine company, by the Defense Logistics Agency Troop Support Medical (DLA Troop Support). The award is for APLIGRAF, a wound care product provided under contract SPE2DE21D0005|SPE2D624F1W56 with a completion date of March 21, 2024. Organogenesis Inc. has been awarded numerous prime federal contracts to provide wound care dressings, surgical implants, tissue regeneration products, and other...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
This is a federal delivery order contract awarded to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the supply of APLIGRAF, a specialized skin substitute product used in advanced wound care treatments. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not utilize any set-aside designations. Organogenesis has been a consistent supplier of wound care and...
This is a fixed-price federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, with a ceiling value of $1,239.95 and a period of performance through June 27, 2025. Organogenesis is an established federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans...
This is a $3,719.85 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The order is for the company's APLIGRAF advanced wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs (VA) for next-generation surgical...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F230M
    Delivery Order

This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024.

Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA Troop Support for surgical implants, tissue regeneration products, and wound care dressings. These contract vehicles, valued up to $49.5 million, demonstrate Organogenesis's role as a key supplier of regenerative medicine solutions to government healthcare programs supporting military personnel and veterans. While this particular delivery order does not utilize a set-aside designation, Organogenesis has participated in small business programs in the past.

Generated 1/28/25, 12:05 PM